Skip to main content
. 2020 May 21;59(7):3325–3338. doi: 10.1007/s00394-020-02282-5

Table 1.

Baseline characteristics of study participants

(n = 25)
Women 10 (40.0)
Age (years) 63.1 (41–73)
Fasting glucose (mmol/L) 8.7 (4.0–12.8)
BMI (kg/m2) 29.1 (19–39)
HbA1C (%) 6.9 (5.1–9.6)
(mmol/mol) 51.9 (32.2–81.4)
Energy (kcal/day) 2338 (1315–4658)
Proteins (E%) 18.1 (9.6–22.9)
Fat (E%) 36.9 (21.7–44.7)
Carbohydrates (E%) 38.9 (27.4–60.3)
Dietary fibre (g/day) 32.2 (9.6–54.7)
Diabetes duration (years) 4.7 (0.2–20.0)
Diabetes treatment
 Diet 8 (32.0)
 Metformin 17 (68.0)
 SLGT2 inhibitorsa 2 (8.0)
 DPP-4 inhibitorsa 5 (20.0)
 Sulfonylureasa 1 (4.0)
 Proton pump inhibitors 0 (0)

Values are mean (range) or n (%)

aMedication used in addition to Metformin